Prothena Corp PLC (PRTA)
20.57
-0.43
(-2.05%)
USD |
NASDAQ |
Apr 18, 16:00
20.60
+0.03
(+0.15%)
After-Hours: 20:00
Prothena Cash from Investing (Quarterly): -1.512M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.512M |
| September 30, 2023 | -0.442M |
| June 30, 2023 | -0.771M |
| March 31, 2023 | -0.048M |
| December 31, 2022 | -0.151M |
| September 30, 2022 | -0.13M |
| June 30, 2022 | -0.161M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -0.319M |
| September 30, 2021 | -0.208M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.048M |
| December 31, 2020 | -0.051M |
| September 30, 2020 | -0.077M |
| June 30, 2020 | -0.046M |
| March 31, 2020 | -0.022M |
| December 31, 2019 | -0.106M |
| September 30, 2019 | -0.249M |
| June 30, 2019 | -0.069M |
| March 31, 2019 | -0.123M |
| December 31, 2018 | -1.297M |
| September 30, 2018 | -0.152M |
| June 30, 2018 | -0.099M |
| March 31, 2018 | -0.181M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.376M |
| September 30, 2017 | -0.538M |
| June 30, 2017 | -0.208M |
| March 31, 2017 | -2.399M |
| December 31, 2016 | -7.147M |
| September 30, 2016 | -8.555M |
| June 30, 2016 | -0.704M |
| March 31, 2016 | -0.238M |
| December 31, 2015 | -0.985M |
| September 30, 2015 | -0.329M |
| June 30, 2015 | -0.04M |
| March 31, 2015 | -0.028M |
| December 31, 2014 | -0.04M |
| September 30, 2014 | -0.106M |
| June 30, 2014 | -0.327M |
| March 31, 2014 | -0.026M |
| December 31, 2013 | 0.003M |
| September 30, 2013 | -0.227M |
| June 30, 2013 | -0.201M |
| March 31, 2013 | -0.11M |
| December 31, 2012 | -1.027M |
| September 30, 2012 | -0.103M |
| June 30, 2012 | -0.034M |
| March 31, 2012 | -0.137M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.512M
Minimum
Dec 2023
--
Maximum
Jun 2021
-0.2333M
Average
-0.106M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp PLC | -71.00M |
| Jazz Pharmaceuticals PLC | 101.80M |
| Iterum Therapeutics PLC | 13.52M |
| GH Research PLC | -0.024M |
| Mural Oncology PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -51.04M |
| Cash from Financing (Quarterly) | 0.483M |
| Free Cash Flow | -136.72M |
| Free Cash Flow Per Share (Quarterly) | -0.9798 |
| Free Cash Flow to Equity (Quarterly) | -52.59M |
| Free Cash Flow to Firm (Quarterly) | -52.59M |
| Free Cash Flow Yield | -12.23% |